Prosecution Insights
Last updated: August 16, 2026

The Cleveland Clinic Foundation

22 pending office actions • 15 art units • 22 examiners • 0 of 22 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days

Portfolio Summary

22
Total Pending OAs
17
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
1
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 7 days (1)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

10
Hard (45%)
8
Medium (36%)
4
Easy (18%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (9%)
§103 only6 (27%)
§112 only3 (14%)
Double-patenting only1 (5%)
Double-patenting + other2 (9%)
Multi-statute (no §101)8 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
32% of docket
1
Information Tech
5% of docket
1
Communications
5% of docket
0
Semiconductors
0% of docket
9
Mechanical / Eng
41% of docket
4
Business / Other
18% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

220 h
Manual time on pending OAs
44 h
Time saved (low, 20%)
77 h
Time saved (mid, 35%)
1.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PERRY, MONICA L 1 55.8% +37.8%
BUKSA, CHRISTOPHER ALLEN 1 73.4% +20.4%
LUONG, PETER 1 69.0% +27.0%
OAKES, JUSTIN MONTGOMERY 1
PARK, EDWARD 1 82.2% +18.0%
JAFFRI, ZEHRA 1 60.5% +46.7%
ZHANG, DUAN 1 61.3% +16.9%
CHESTNUT, BARRY A 1 73.4% +6.3%
JOHNSON, NICOLE F 1 87.5% +7.2%
TEJANI, ANKIT D 1 81.0% +16.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18667194 3D QUANTITATIVE JOINT MUSCLE EVALUATION VIA AUTOMATED JOINT MUSCLE SEGMENTATION WITH ARTIFICIAL INTELLIGENCE PARK, EDWARD

Hard Cases (10)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18003807 COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION LEE, CHIHYI NMN 6d
18599646 STABILIZING FRAMES AND METHODS OF POSITIONING WITH A STABILIZING FRAME JOHNSON, NICOLE F 8d
19036237 AUTOMATIC CARDIOVASCULAR MAGNETIC RESONANCE IMAGING LUONG, PETER
18891486 SYSTEM AND METHOD FOR DIAGNOSING INFLAMMATORY BOWEL DISEASE STATE AND SEVERITY OAKES, JUSTIN MONTGOMERY
18640197 SYNTHETIC TABULAR NEURAL GENERATOR ZHANG, DUAN
18701156 MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE CHESTNUT, BARRY A
18392491 SYSTEMS AND METHODS TO IMPROVE SLEEP DISORDERED BREATHING USING CLOSED-LOOP FEEDBACK TEJANI, ANKIT D
18263929 TREATMENT OF CVD AND SYSTEMIC SCEROSIS WITH BETA-1 ADRENERGIC RECEPTOR ANTIBODIES BUNNER, BRIDGET E

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
19157779 HEAD FIXATION DEVICE PERRY, MONICA L
19198193 COMPLIANCE CORRECTION IN A ROBOTIC SYSTEM BUKSA, CHRISTOPHER ALLEN
19036237 AUTOMATIC CARDIOVASCULAR MAGNETIC RESONANCE IMAGING LUONG, PETER
18667194 3D QUANTITATIVE JOINT MUSCLE EVALUATION VIA AUTOMATED JOINT MUSCLE SEGMENTATION WITH ARTIFICIAL INTELLIGENCE PARK, EDWARD
18659920 METHOD AND APPARATUSES FOR ACCESSING AND/OR MODIFYING A TARGET PATIENT TISSUE SITE JAFFRI, ZEHRA
18640197 SYNTHETIC TABULAR NEURAL GENERATOR ZHANG, DUAN
18392491 SYSTEMS AND METHODS TO IMPROVE SLEEP DISORDERED BREATHING USING CLOSED-LOOP FEEDBACK TEJANI, ANKIT D

Top Art Units

Art UnitApps
3797 2
3771 2
3796 2
3644 1
2675 1
1633 1
1616 1
1625 1
1647 1
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19157779 HEAD FIXATION DEVICE PERRY, MONICA L 3644 §112 Non-Final OA Pending Aug 19, 2025
19198193 COMPLIANCE CORRECTION IN A ROBOTIC SYSTEM BUKSA, CHRISTOPHER ALLEN §112 Non-Final OA Pending May 05, 2025
19036237 AUTOMATIC CARDIOVASCULAR MAGNETIC RESONANCE IMAGING LUONG, PETER 3797 §102§103 Non-Final OA Pending Jan 24, 2025
18891486 SYSTEM AND METHOD FOR DIAGNOSING INFLAMMATORY BOWEL DISEASE STATE AND SEVERITY OAKES, JUSTIN MONTGOMERY §101§103 Non-Final OA Pending Sep 20, 2024
18667194 3D QUANTITATIVE JOINT MUSCLE EVALUATION VIA AUTOMATED JOINT MUSCLE SEGMENTATION WITH ARTIFICIAL INTELLIGENCE PARK, EDWARD 2675 §103 Non-Final OA Pending May 17, 2024
18659920 METHOD AND APPARATUSES FOR ACCESSING AND/OR MODIFYING A TARGET PATIENT TISSUE SITE JAFFRI, ZEHRA 3771 §112 Non-Final OA Pending May 09, 2024
18640197 SYNTHETIC TABULAR NEURAL GENERATOR ZHANG, DUAN §101§102§103§112 Non-Final OA Pending Apr 19, 2024
18701156 MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE CHESTNUT, BARRY A §103§112 Non-Final OA Pending Apr 12, 2024
18599646 STABILIZING FRAMES AND METHODS OF POSITIONING WITH A STABILIZING FRAME JOHNSON, NICOLE F 3796 §102§112 Non-Final OA 8d Pending Mar 08, 2024
18392491 SYSTEMS AND METHODS TO IMPROVE SLEEP DISORDERED BREATHING USING CLOSED-LOOP FEEDBACK TEJANI, ANKIT D 3796 §102§103Other Final Rejection Pending Dec 21, 2023
18528348 GENERATING QUIESCENT HEPATIC STELLATE CELLS AND THEIR USE IN LIVER MODELS LARA, CAROLINE MONSERRAT 1633 §102§103§112DP Non-Final OA Pending Dec 04, 2023
18566802 NON-CONTACT LITHOTRIPSY USING PHOTONIC NANOPARTICLES ARMSTRONG, SUSANNAH SIPPLE 1616 §102§103§112DP Non-Final OA Pending Dec 04, 2023
18482074 BALLOON CATHETER RODJOM, KATHERINE MARIE 3771 §103 Non-Final OA Pending Oct 06, 2023
18478684 TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY MAHLUM, JONATHAN DAVIS 1625 DP Non-Final OA Pending Sep 29, 2023
18263929 TREATMENT OF CVD AND SYSTEMIC SCEROSIS WITH BETA-1 ADRENERGIC RECEPTOR ANTIBODIES BUNNER, BRIDGET E 1647 §102§112 Non-Final OA Pending Aug 02, 2023
18111138 PROTECTIVE COVER DANIEL, ANTARIUS S 3783 §103 Final Rejection Pending Feb 17, 2023
18104712 OPTIMIZING SPINE SCREW PLACEMENT SAXENA, AKASH 2188 §102§103 Non-Final OA Pending Feb 01, 2023
18003807 COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION LEE, CHIHYI NMN 1628 §102§103§112Other Non-Final OA 6d Pending Dec 29, 2022
18001832 TREATMENT OF VIRAL INFECTIONS WITH ESTROGEN RECEPTOR MODULATORS AND ANTI-INFLAMMATORY AGENTS HAVLIN, ROBERT H 1626 §103 Final Rejection 45d overdue Pending Dec 14, 2022
17854597 RADIOPAQUE TISSUE MARKER TALTY, MARIA CHRISTINA 3797 §103 Final Rejection Pending Jun 30, 2022
17281324 METHOD FOR DIAGNOSING CLOSTRIDIOIDES DIFFICILE INFECTION PORTILLO, JAIRO H 3791 §103 Final Rejection Pending Mar 30, 2021
16982090 THERMORESPONSIVE COMPOSITIONS AND METHODS FOR PREVENTING AND DISRUPTING BIOFILMS WRIGHT, SARAH C 1619 §103§112 Non-Final OA Pending Sep 18, 2020

Managing The Cleveland Clinic Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month